ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA MNK PHARMACEUTICALS)

Lobbying for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS (FKA ST SHARED SERVICES LLC DBA

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Missouri · House · Senate · $220,000.00 expenses · posted Apr 21, 2025

Lobbying activity 3

Medicare/Medicaid

Inflation Reduction Act Reimbursement for Domestically Manufactured Pharmaceuticals

Taxation/Internal Revenue Code

Infrastructure Investment & Jobs Act, Solar Tax Credit

Health Issues

Pandemic All Heath Preparedness Act re-authorization, Industrial Base Expansion

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.